Preprints
https://doi.org/10.5194/egusphere-2025-1031
https://doi.org/10.5194/egusphere-2025-1031
23 Apr 2025
 | 23 Apr 2025

Atmospheric and watershed modelling of HFO-1234ze(E) emissions from prospective pressurized metered-dose inhalers usage

Shivendra G. Tewari, Krish Vijayaraghavan, Kun Zhao, Liji M. David, Katie Tuite, Felix Kristanovich, Yuan Zhuang, Benjamin Yang, Cecilia Hurtado, Dimitrios K. Papanastasiou, Paul Giffen, Holly Kimko, Megan Gibbs, and Stefan Platz

Abstract. HFO-1234ze(E) is a next-generation medical propellant in development for use in pressurized metered-dose inhalers (pMDIs). The chemical structure of HFO-1234ze(E) has the ‘–CF3’ moiety, which makes formation of trifluoroacetic acid (TFA) possible in the atmosphere. To quantify the contribution of these novel pMDIs in forming environmental TFA, we performed an extensive study using a global atmospheric model coupled with detailed watershed modelling. Herein, we included the master-chemical mechanism of HFO-1234ze(E), accounting for all known pathways that may form atmospheric TFA and assumed pMDI usage as the only source of HFO-1234ze(E) emissions. Based on annual pMDI sales data and HFO-1234ze(E) as their sole medical propellant, we estimate annual global propellant emissions of 4.736 Gg/year. Even though pMDI sales are the highest in regions within the northern-temperate zone, model-predicted TFA deposition rates are higher in regions within the tropical zone, suggesting that photolysis reaction of trifluoroacetic aldehyde (TFAA; which does not yield TFA) is dominant in the northern-temperate zone. We used model-predicted TFA deposition rates around the Hudson River, Cauvery River, and Rhine River as an input to our fate-and-transport model of TFA, yielding pMDI usage-based TFA concentrations in surface water, soil and sediments in each of the three modelled watersheds. Our watershed models predict that TFA concentrations in river surface water would vary between 0.8–19.3 ng/L, indicating greater than 500-fold margin-of-exposure for drinking-water TFA. Our results demonstrate that environmental TFA formation due to pMDI usage-based HFO-1234ze(E) emissions do not pose a human health concern.

Competing interests: SGT, PG, HK, MG, and SP are employees of AstraZeneca and hold shares/share options in AstraZeneca. KV, KZ, LMD, KT, FK, YZ, and BY are employees of Ramboll. DKP is an employee of Honeywell.

Publisher's note: Copernicus Publications remains neutral with regard to jurisdictional claims made in the text, published maps, institutional affiliations, or any other geographical representation in this paper. While Copernicus Publications makes every effort to include appropriate place names, the final responsibility lies with the authors. Views expressed in the text are those of the authors and do not necessarily reflect the views of the publisher.
Share
Shivendra G. Tewari, Krish Vijayaraghavan, Kun Zhao, Liji M. David, Katie Tuite, Felix Kristanovich, Yuan Zhuang, Benjamin Yang, Cecilia Hurtado, Dimitrios K. Papanastasiou, Paul Giffen, Holly Kimko, Megan Gibbs, and Stefan Platz

Status: final response (author comments only)

Comment types: AC – author | RC – referee | CC – community | EC – editor | CEC – chief editor | : Report abuse
  • RC1: 'Comment on egusphere-2025-1031', Anonymous Referee #1, 14 May 2025
  • RC2: 'Comment on egusphere-2025-1031', Anonymous Referee #2, 23 Jun 2025
Shivendra G. Tewari, Krish Vijayaraghavan, Kun Zhao, Liji M. David, Katie Tuite, Felix Kristanovich, Yuan Zhuang, Benjamin Yang, Cecilia Hurtado, Dimitrios K. Papanastasiou, Paul Giffen, Holly Kimko, Megan Gibbs, and Stefan Platz
Shivendra G. Tewari, Krish Vijayaraghavan, Kun Zhao, Liji M. David, Katie Tuite, Felix Kristanovich, Yuan Zhuang, Benjamin Yang, Cecilia Hurtado, Dimitrios K. Papanastasiou, Paul Giffen, Holly Kimko, Megan Gibbs, and Stefan Platz

Viewed

Total article views: 976 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
768 190 18 976 35 16 34
  • HTML: 768
  • PDF: 190
  • XML: 18
  • Total: 976
  • Supplement: 35
  • BibTeX: 16
  • EndNote: 34
Views and downloads (calculated since 23 Apr 2025)
Cumulative views and downloads (calculated since 23 Apr 2025)

Viewed (geographical distribution)

Total article views: 991 (including HTML, PDF, and XML) Thereof 991 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 18 Sep 2025
Download
Short summary
The study reveals that using HFO-1234ze(E) propellant in pMDIs significantly reduces environmental impact compared to present-day propellants, with negligible trifluoroacetic acid (TFA) formation that poses no health risk. It demonstrates that this next-generation medical propellant not only supports climate goals but also provides a sustainable substitution to present-day propellants, ensuring the future supply of pMDIs to people living with chronic respiratory diseases.
Share